Vraylar Capsule, Gelatin Coated
Product Images NDC 61874-115

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Vraylar (NDC 61874-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure For Vraylar Is Cariprazine HCl, An Atypical Antipsychotic. The Chemical Name Is Trans-n-{4-[2-[4-(2,3 Dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-n’,n’-dimethylurea Hydrochloride; Its Empirical Formula Is C21h33cl3n4o And Its Molecular Weight Is 463.9 G/mol. (Vraylar 01)

FDA Label Image

Figure 1. Plasma Concentration (mean ± Se)-time Profile During And Following12-weeks Of Treatment With Cariprazine 6 mg/daya (Vraylar 02)

FDA Label Image

Figure 2 Change From Baseline In Panss Total Score By Weekly Visits (study 2) (Vraylar 03)

FDA Label Image

Figure 3 Kaplan-meier Curves Of Cumulative Rate Of Relapse During The Double-blind Treatment Period (Vraylar 04)

FDA Label Image

Figure 4 Change From Baseline In Ymrs Total Score By Study Visit (study 1) (Vraylar 05)

This is a medication called Vraylaré, and it comes in capsule form with a strength of 1.5 mg per capsule. Prescribers are instructed to give a medication guide to each patient. More information can be found at www.vraylar.com.*

FDA Label Image

Principal Display Panelndc 61874-115-17vraylar(cariprazine) Capsules1.5 mg Per Capsule7 Capsulesrx Only (Vraylar 06)

Vraylaré is a prescription drug that comes in the form of B (cariprazine) capsules with 1.5 mg per capsule, packed in a child-resistant package. The package contains 7 capsules and can be opened by following the instructions on the blister card. For further information, visit www.vraylar.com, and don't forget to read the enclosed Medication Guide for full patient information. The rest of the text is not available.*

FDA Label Image

Principal Display Panelndc 61874-115-30vraylar(cariprazine) Capsules1.5 mg Per Capsule30 Capsulesrx Only (Vraylar 07)

Vraylar is a medication that comes in capsules with a strength of 1.5 mg per capsule.*

FDA Label Image

Principal Display Panelndc 61874-115-90vraylar(cariprazine) Capsules1.5 mg Per Capsule90 Capsulesrx Only (Vraylar 08)

The text seems to be an unclear mix of product information and random characters. It is not possible to generate a useful description.*

FDA Label Image

Principal Display Panelndc 61874-115-20vraylar(cariprazine) Capsules1.5 mg Per Capsule20 Capsules (2x10-count Blister Cards)rx Only (Vraylar 09)

Vraylars (cariprazine) capsules are available in 15 mg strength. Prescribers are advised to provide the medication guide to each patient. For more information, visit www.vraylar.com.*

FDA Label Image

Principal Display Panelndc 61874-170-08vraylar(cariprazine) Capsulesone 1.5 mg Capsule And Six 3 mg Capsules7 Capsulesrx Only (Vraylar 0a)

FDA Label Image

Principal Display Panelndc 61874-130-30vraylar(cariprazine) Capsules3 mg Per Capsule30 Capsulesrx Only (Vraylar 0b)

FDA Label Image

Principal Display Panelndc 61874-130-90vraylar(cariprazine) Capsules3 mg Per Capsule90 Capsulesrx Only (Vraylar 0c)

The text seems to be a representation of the dosage or strength (0.5g per capsule) of a medication or supplement called "Vraylar".*

FDA Label Image

Principal Display Panelndc 61874-130-20vraylar(cariprazine) Capsules3 mg Per Capsule20 Capsules (2x10-count Blister Cards)rx Only (Vraylar 0d)

Vraylar is a medication available in capsules containing 6mg of the active ingredient. Any further information about the medication is not available from this text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.